Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

[Formation of models of the interaction between organophosphate compound structure and their ability to inhibit cholinesterase].

Raevskiĭ OA, Chistiakov VV, Agabekian RS, Sapegin AM, Zefirov NS.

Bioorg Khim. 1990 Nov;16(11):1509-22. Russian.

PMID:
2096825
[PubMed - indexed for MEDLINE]
2.

Cholinesterase inhibition: complexities in interpretation.

Lotti M.

Clin Chem. 1995 Dec;41(12 Pt 2):1814-8. Review.

PMID:
7497638
[PubMed - indexed for MEDLINE]
Free Article
3.

Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents.

Gray AP.

Drug Metab Rev. 1984;15(3):557-89. Review. No abstract available.

PMID:
6386410
[PubMed - indexed for MEDLINE]
4.

Human acetylcholinesterase inhibitors: electronic-topological and neural network approaches to the structure-activity relationships study.

Kandemirli F, Saraçoglu M, Kovalishyn V.

Mini Rev Med Chem. 2005 May;5(5):479-87. Review.

PMID:
15892689
[PubMed - indexed for MEDLINE]
5.

Mechanisms of organophosphate toxicity and detoxication with emphasis on studies in Croatia.

Reiner E, Radić Z, Simeon-Rudolf V.

Arh Hig Rada Toksikol. 2007 Sep;58(3):329-38. Review.

PMID:
17913688
[PubMed - indexed for MEDLINE]
6.

Organophosphate intoxication: pharmacologic, neurophysiologic, clinical, and therapeutic considerations.

Gutmann L, Besser R.

Semin Neurol. 1990 Mar;10(1):46-51. Review. No abstract available.

PMID:
2189180
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk